Ignite Creation Date:
2025-12-24 @ 3:58 PM
Ignite Modification Date:
2026-01-02 @ 7:01 AM
Study NCT ID:
NCT04123392
Status:
UNKNOWN
Last Update Posted:
2019-10-10
First Post:
2019-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-09
First Submit QC Date:
None
Study First Post Date:
2019-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-09
Last Update Post Date:
2019-10-10
Last Update Post Date Type:
ACTUAL